Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Cholangitis
10
Clinical Trials
4
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT02978339
A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)
Completed · Phase 1|Phase 2
NCT01088607
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Completed · Phase 1
NCT03188146
Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid
Recruiting
📊 Sample Meta-Analyses
CRD42022326534
Effect of ursodeoxycholic acid on the outcome of biliary atresia: A systematic review and meta-analysis
Biliary atresia (BA) is a common hepatic disease affecting only neonates and inf
CRD42021276554
Effect of Ursodeoxycholic Acid on development of Cholangiocarcinoma in patients with Primary Sclerosing Cholangitis: A Systematic Review
Cholangiocarcinoma in patients with Primary Sclerosing Cholangitis
CRD42023476195
Efficacy of Ursodeoxycholic Acid in Preventing the Recurrence of Common Bile Duct Stones after ERCP Lithotomy: a Meta-Analysis
An updated CBDS management guideline requires that even asymptomatic patients wi
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Cholangitis
🏥 Names
Disease Name
Cholangitis
Alias Names
Ascending Cholangitis; Sclerosing Cholangitis; Suppurative Cholangitis; Bile Duct Inflammation; Cholangitis
Topic Type
syndrome
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Disease or Syndrome
MeSH Class
Digestive System Diseases
HPO Class
Abnormality of the immune system; Abnormality of the digestive system
DO Class
disease of anatomical entity
🔗 External References
HERB DB
MeSH
ICD-10
HPO
Disease Ontology
14270; 14269; 9446; 14268
DisGeNET
C0008311
🔍 Raw view — every non-empty column on this row (30 fields)
name
Cholangitis
alias name
Ascending Cholangitis; Sclerosing Cholangitis; Suppurative Cholangitis; Bile Duct Inflammation; Cholangitis
topic type
syndrome
disgenet disease type
disease
umls disease type
Disease or Syndrome
mesh disease class
Digestive System Diseases
hpo disease class
Abnormality of the immune system; Abnormality of the digestive system
do disease class
disease of anatomical entity
umls disease type id
T047
mesh disease class id
C06
hpo disease class id
HP:0025031; HP:0002715
do disease class id
DOID:7
herb disease id
HBDIS000545
disgenet id
C0008311
mesh id
D002761
hpo id
HP:0030151
do id
14270; 14269; 9446; 14268
icd10 id
K83.0
⚗️ Related Ingredients
2 · compounds in this herb📋 Clinical Trials
10 · subject of clinical studyNCT02978339 A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary
→ Primary Sclerosing Cholangitis
NCT01088607 Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary S
→ Primary Sclerosing Cholangitis
NCT03188146 Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangi
→ Primary Biliary Cholangitis (PBC)
NCT04617561 Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of P
→ Hepatitis, Autoimmune|Primary Biliary Cholangitis
NCT04618575 Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment o
→ Hepatitis|Primary Biliary Cholangitis|Autoimmune
NCT04650243 Clinical Research of UCDA Reducing Medication Regimen in Stable PBC
→ Primary Biliary Cholangitis
NCT02936596 Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap
→ Hepatitis, Autoimmune|Cholangitis|Liver Cirrhosis,
NCT05751967 Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary
→ Primary Biliary Cholangitis
NCT06174402 Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangi
→ Primary Biliary Cholangitis
NCT05749822 Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
→ Primary Biliary Cholangitis
📊 Meta-Analyses
4 · systematic reviewCRD42022326534 Effect of ursodeoxycholic acid on the outcome of biliary atresia: A systematic r
→ Biliary atresia (BA) is a common hepatic disease a
CRD42021276554 Effect of Ursodeoxycholic Acid on development of Cholangiocarcinoma in patients
→ Cholangiocarcinoma in patients with Primary Sclero
CRD42023476195 Efficacy of Ursodeoxycholic Acid in Preventing the Recurrence of Common Bile Duc
→ An updated CBDS management guideline requires that
CRD42023487138 Investigating the effects of adding fenofibrate to ursodeoxycholic acid in patie
→ Primary biliary cholangitis is an autoimmune disea
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables